Your browser doesn't support javascript.
loading
Mitochondrial metabolomic profiling for elucidating the alleviating potential of Polygonatum kingianum against high-fat diet-induced nonalcoholic fatty liver disease.
Yang, Xing-Xin; Wei, Jia-Di; Mu, Jian-Kang; Liu, Xin; Li, Feng-Jiao; Li, Yan-Qin; Gu, Wen; Li, Jing-Ping; Yu, Jie.
Afiliação
  • Yang XX; College of Pharmaceutical Science, Yunnan University of Chinese Medicine, Kunming 650500, Yunnan Province, China.
  • Wei JD; College of Pharmaceutical Science, Yunnan University of Chinese Medicine, Kunming 650500, Yunnan Province, China.
  • Mu JK; College of Pharmaceutical Science, Yunnan University of Chinese Medicine, Kunming 650500, Yunnan Province, China.
  • Liu X; Beijing Entry-Exit Inspection and Quarantine Bureau, Beijing 100026, China.
  • Li FJ; College of Pharmaceutical Science, Yunnan University of Chinese Medicine, Kunming 650500, Yunnan Province, China.
  • Li YQ; College of Pharmaceutical Science, Yunnan University of Chinese Medicine, Kunming 650500, Yunnan Province, China.
  • Gu W; College of Pharmaceutical Science, Yunnan University of Chinese Medicine, Kunming 650500, Yunnan Province, China.
  • Li JP; College of Pharmaceutical Science, Yunnan University of Chinese Medicine, Kunming 650500, Yunnan Province, China.
  • Yu J; College of Pharmaceutical Science, Yunnan University of Chinese Medicine, Kunming 650500, Yunnan Province, China. cz.yujie@gmail.com.
World J Gastroenterol ; 25(43): 6404-6415, 2019 Nov 21.
Article em En | MEDLINE | ID: mdl-31798277
ABSTRACT

BACKGROUND:

Developing mitochondrial regulators/nutrients from natural products to remedy mitochondrial dysfunction represent attractive strategies for therapy of non-alcoholic fatty liver disease (NAFLD). Polygonatum kingianum (PK) has been traditionally used in China as a medicinal and nutritional ingredient for centuries and can alleviate high-fat diet (HFD)-induced NAFLD by promoting mitochondrial functions. To date, the underlying molecular mechanism of PK for treating mitochondrial dysfunctions and thus alleviating NAFLD remains unclear.

AIM:

To identify the molecular mechanism behind the mitochondrial regulatory action of PK against HFD-induced NAFLD in rats.

METHODS:

NAFLD model was induced in rats with HFD. The rats were intragastrically administered PK (4 g/kg per day) for 14 wk. Metabolites in hepatic mitochondrial samples were profiled through ultra-high performance liquid chromatography/mass spectrometry followed by multivariate statistical analysis to find the potential biomarkers and metabolic pathways.

RESULTS:

PK significantly restored the metabolites' levels in the mitochondrial samples. Ten potential biomarkers were identified in the analyzed samples. These biomarkers are involved in riboflavin metabolism.

CONCLUSION:

PK can alleviate HFD-induced NAFLD by regulating the riboflavin metabolism and further improving the mitochondrial functions. Thus, PK is a promising mitochondrial regulator/nutrient for alleviating NAFLD-associated diseases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mitocôndrias Hepáticas / Medicamentos de Ervas Chinesas / Polygonatum / Metaboloma / Hepatopatia Gordurosa não Alcoólica Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mitocôndrias Hepáticas / Medicamentos de Ervas Chinesas / Polygonatum / Metaboloma / Hepatopatia Gordurosa não Alcoólica Idioma: En Ano de publicação: 2019 Tipo de documento: Article